0

Recombinant Proteins Market by Application and Geography - Forecast and Analysis 2022-2026

  • Published: Aug 2022
  • Pages: 144
  • SKU: IRTNTR74151
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The recombinant proteins market share is expected to increase by USD 633.23 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 9.98%.

This recombinant proteins market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers recombinant proteins market segmentation by application (biotechnology research, drug discovery and development, biopharmaceutical production, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The recombinant proteins market report also offers information on several market vendors, including Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., GigaGen Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi, Sino Biological Inc., and Thermo Fisher Scientific Inc. among others.

What will the Recombinant Proteins Market Size be During the Forecast Period?

Recombinant Proteins Market Size

Download Report Sample to Unlock the Recombinant Proteins Market Size for the Forecast Period and Other Important Statistics

 

Recombinant Proteins Market: Key Drivers, Trends, and Challenges

The increase in chronic diseases is notably driving the recombinant proteins market growth, although factors such as complexities in manufacturing, storage conditions, and high costs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the recombinant proteins industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Recombinant Proteins Market Driver

An increase in chronic diseases is one of the major drivers impacting the recombinant proteins market growth. Major chronic diseases, such as cancer, cardiovascular diseases, endocrine diseases, and viral disorders, are all treated with recombinant proteins. During the forecast period, an increase in the prevalence of such types of diseases is anticipated to fuel the demand for recombinant proteins. The World Health Organization estimates that cancer is the second-leading cause of death worldwide, accounting for 10 million deaths in 2020. About 1 in 6 deaths worldwide are caused by cancer. These diseases are caused by high blood pressure, high blood cholesterol, and obesity, as well as by unhealthy diet, physical inactivity, and tobacco use. The Canadian Cancer Society reports that by 2030, there will likely be a 40% increase in the number of new cancer cases in Canada. The prevalence of cardiovascular and cancer disorders is rising globally. For instance, according to the IARC, in 2020, the rate of new cancer cases was 19.3 million. Similarly, the increasing prevalence of other chronic conditions, such as cardiovascular diseases and neurological disorders, will augment the demand for recombinant proteins during the forecast period.

Key Recombinant Proteins Market Trend

Increased expenditure on R&D is one of the major trends influencing the recombinant proteins market growth. The R&D industry has historically required a lot of capital due to lengthy approval processes. Spending on R&D is a significant portion of the global healthcare budget. Governments recognize that R&D is essential to a nation's economy, competitiveness abroad, and public benefits. As a result, funding and spending on R&D have risen gradually over time, which is predicted to drive the growth of the global recombinant proteins market during the forecast period. In 2020, R&D spending in the pharmaceutical industry totaled nearly $200 billion globally. The global recombinant proteins market has grown and developed tremendously as a result of increased investments in R&D, which have resulted in the launch of new protein therapies. For instance, in January 2020, Airway Therapeutics obtained $15.5 million in a Series C investment transaction to advance its AT-100 unique recombinant human protein rhSP-D, an investigational preventive therapy for the critical respiratory condition bronchopulmonary dysplasia (BPD). Thus, increased investments in R&D drive the growth of the global recombinant proteins market during the forecast period.

Key Recombinant Proteins Market Challenge

Complexities in manufacturing, storage conditions, and high costs is one of the major challenges impeding the recombinant proteins market growth. Proteins are prepared from living organisms, unlike small-molecule drugs. Hence, the manufacturing process involved is very complex and time-consuming. The process involves methods such as fermentation, clarification, separation, and purification. The process of separation is difficult as different molecules differ slightly from each other. The purification process is also lengthy, and the risk of contamination is high as the drug is produced in a biological medium. Analytical methods such as high-performance liquid chromatography (HPLC) and spectroscopy are used to separate, identify, and quantify each component in a mixture. All through the process, proper temperature, pressure, and pH should be maintained. Thus, the variation between products manufactured by different companies underscores the challenges in producing biopharmaceutical proteins to consistent standards. 

This recombinant proteins market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global recombinant proteins market as a part of the global biotechnology market within the overall healthcare industry. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the recombinant proteins market during the forecast period.

Who are the Major Recombinant Proteins Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abcam plc
  • Airway Therapeutics Inc.
  • Amgen Inc.
  • Aviva Systems Biology Corp.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • BPS Bioscience Inc.
  • Elabscience Biotechnology Inc.
  • Enzo Biochem Inc.
  • GenScript Biotech Corp.
  • GigaGen Inc.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk AS
  • OriGene Technologies Inc.
  • Prospec Tany Technogene Ltd.
  • Proteintech Group Inc.
  • Sanofi
  • Sino Biological Inc.
  • Thermo Fisher Scientific Inc.

 

This statistical study of the recombinant proteins market encompasses successful business strategies deployed by the key vendors. The recombinant proteins market is fragmented and the vendors are deploying growth strategies such as acquiring other smaller brands to increase their market presence to compete in the market.

Product Insights and News

  • abcam.com - The company offers proteins that are manipulated versions of native proteins produced using recombinant DNA to generate large amounts of a specific protein.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The recombinant proteins market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Recombinant Proteins Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the recombinant proteins market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Recombinant Proteins Market?

Recombinant Proteins Market Share by Geography

For more insights on the market share of various regions Request PDF Sample now!

36% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for the recombinant proteins market in North America. Market growth in this region will be faster than the growth of the market in other regions.

The increasing prevalence of diseases, such as cancer, autoimmune diseases, metabolic diseases, musculoskeletal disorders, central nervous system disorders, and blood disorders will facilitate the recombinant proteins market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 in 2020 severely impacted the recombinant proteins market in North America. The exponential rise in the number of COVID-19 cases compelled the governments of various countries in the region to impose restrictions on businesses and transportation activities, which led to the closure of laboratories and clinical research centers. The pandemic decreased the manufacturing of recombinant proteins owing to government restrictions on the movement of people. In 2021, the initiation of vaccination programs led to the resumption of business operations, including the supply chain of recombinant proteins.

What are the Revenue-generating Application Segments in the Recombinant Proteins Market?

Recombinant Proteins Market Share

To gain further insights on the market contribution of various segments Request a PDF Sample

The recombinant proteins market share growth in the biotechnology research segment will be significant during the forecast period. Recombinant proteins highly contribute to significant advances in biomedical biotechnology. A larger number of recombinant proteins is used in the research laboratory.

This report provides an accurate prediction of the contribution of all the segments to the growth of the recombinant proteins market size and actionable market insights on post COVID-19 impact on each segment.

 

Recombinant Proteins Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 9.98%

Market growth 2022-2026

$ 633.23 million

Market structure

Fragmented

YoY growth (%)

9.5

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key consumer countries

US, Canada, Germany, Italy, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., GigaGen Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi, Sino Biological Inc., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Recombinant Proteins Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive recombinant proteins market growth during the next five years
  • Precise estimation of the recombinant proteins market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the recombinant proteins industry across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of recombinant proteins market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Application

    • 5.1 Market segments
      • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
    • 5.2 Comparison by Application
      • Exhibit 26: Chart on Comparison by Application
      • Exhibit 27: Data Table on Comparison by Application
    • 5.3 Biotechnology research - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Biotechnology research - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Biotechnology research - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Biotechnology research - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Biotechnology research - Year-over-year growth 2021-2026 (%)
    • 5.4 Drug discovery and development - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Drug discovery and development - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Drug discovery and development - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Drug discovery and development - Year-over-year growth 2021-2026 (%)
    • 5.5 Biopharmaceutical production - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Biopharmaceutical production - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Biopharmaceutical production - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Biopharmaceutical production - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Biopharmaceutical production - Year-over-year growth 2021-2026 (%)
    • 5.6 Others - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by Application
      • Exhibit 44: Market opportunity by Application ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.9 Germany - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.10 Italy - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Italy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Italy - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Italy - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Canada - Market size and forecast 2021-2026
      • Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.13 Market opportunity by geography
      • Exhibit 90: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 93: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 94: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 95: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 96: Matrix on vendor position and classification
            • 10.3 Abcam plc
              • Exhibit 97: Abcam plc - Overview
              • Exhibit 98: Abcam plc - Product / Service
              • Exhibit 99: Abcam plc - Key news
              • Exhibit 100: Abcam plc - Key offerings
            • 10.4 Amgen Inc.
              • Exhibit 101: Amgen Inc. - Overview
              • Exhibit 102: Amgen Inc. - Product / Service
              • Exhibit 103: Amgen Inc. - Key offerings
            • 10.5 Bio Rad Laboratories Inc.
              • Exhibit 104: Bio Rad Laboratories Inc. - Overview
              • Exhibit 105: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 106: Bio Rad Laboratories Inc. - Key news
              • Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
            • 10.6 Enzo Biochem Inc.
              • Exhibit 109: Enzo Biochem Inc. - Overview
              • Exhibit 110: Enzo Biochem Inc. - Business segments
              • Exhibit 111: Enzo Biochem Inc. - Key offerings
              • Exhibit 112: Enzo Biochem Inc. - Segment focus
            • 10.7 Merck KGaA
              • Exhibit 113: Merck KGaA - Overview
              • Exhibit 114: Merck KGaA - Business segments
              • Exhibit 115: Merck KGaA - Key news
              • Exhibit 116: Merck KGaA - Key offerings
              • Exhibit 117: Merck KGaA - Segment focus
            • 10.8 Novartis AG
              • Exhibit 118: Novartis AG - Overview
              • Exhibit 119: Novartis AG - Business segments
              • Exhibit 120: Novartis AG - Key offerings
              • Exhibit 121: Novartis AG - Segment focus
            • 10.9 Novo Nordisk AS
              • Exhibit 122: Novo Nordisk AS - Overview
              • Exhibit 123: Novo Nordisk AS - Business segments
              • Exhibit 124: Novo Nordisk AS - Key offerings
              • Exhibit 125: Novo Nordisk AS - Segment focus
            • 10.10 Sanofi
              • Exhibit 126: Sanofi - Overview
              • Exhibit 127: Sanofi - Business segments
              • Exhibit 128: Sanofi - Key news
              • Exhibit 129: Sanofi - Key offerings
              • Exhibit 130: Sanofi - Segment focus
            • 10.11 Sino Biological Inc.
              • Exhibit 131: Sino Biological Inc. - Overview
              • Exhibit 132: Sino Biological Inc. - Product / Service
              • Exhibit 133: Sino Biological Inc. - Key offerings
            • 10.12 Thermo Fisher Scientific Inc.
              • Exhibit 134: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 135: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 136: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 137: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 138: Thermo Fisher Scientific Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 139: Inclusions checklist
                • Exhibit 140: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 141: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 142: Research methodology
                • Exhibit 143: Validation techniques employed for market sizing
                • Exhibit 144: Information sources
              • 11.5 List of abbreviations
                • Exhibit 145: List of abbreviations
              • investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                TechnavioINFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases
                Technavio

                TechnavioDATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts
                Technavio

                TechnavioREPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape
                Interested in this report?
                Get your sample now!
                Recombinant Proteins market growth will increase by $633.23 million during 2022-2026.
                The recombinant proteins market is expected to grow at a CAGR of 9.98% during 2022-2026.
                Technavio has segmented the recombinant proteins market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
                Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., GigaGen Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi, Sino Biological Inc., Thermo Fisher Scientific Inc. are a few of the key vendors in the recombinant proteins market.
                North America will register the highest growth rate of 35.96% among the other regions. Therefore, the recombinant proteins market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
                • US
                • Canada
                • Germany
                • Italy
                • China
                • Japan
                The key factors driving the recombinant proteins market growth are:
                • Increase in chronic diseases
                • Increase in collaborations and strategic alliances by vendors
                The recombinant proteins market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?
                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis

                Certified ISO 9001 : 2015

                We are ISO recognized

                We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                We are GDPR and CCPA compliant

                We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                Safe and Secure SSL Encrypted
                Technavio

                info
                close
                • Single:

                  One user only.
                  Quick & easy download option

                • Enterprise:

                  Unlimited user access (Within your organization)
                  Complimentary Customization Included

                2500 USD

                Technavio Get the report (PDF) sent to your email within minutes.

                Subscribe & Save

                Get lifetime access to our
                Technavio Insights

                Customized Report as per your Business Needs

                • Our analysts will work directly with you and understand your needs
                • Get data on specified regions or segments, competitor and Vendors
                • Data will be formatted and presented as per your requirements
                • We offer $1000 worth of FREE customization at the time of purchase

                Let us help you make report more suited to your requirements.

                • Get a competitive breakdown as per your niche industry
                • Customize the data with various metrics that meet your business prerequisite
                • Understand Revenue Sources, Customers and many more
                • Details on Market Share
                • These customizations are done in a short amount of time by our analysts and industry experts
                Technavio
                Enquire Before Buying
                17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>